Drugmart India Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.68 M
- Revenue Growth 4.27%
- Profit Growth -138.39%
- Ebitda -213.90%
- Net Worth -3.82%
- Total Assets 3.31%
About Drugmart India
Drugmart India Private Limited (DIPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 December 2013 and has a history of 11 years and one month. Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company has closed loans amounting to ₹5.68 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Manish Singla and Ankita Singla serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U51397CH2013PTC034866
-
Company No.
034866
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Dec 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Drugmart India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Singla
|
Director | 10-Dec-2013 | Current |
|
Ankita Singla
|
Director | 23-Feb-2016 | Current |
Financial Performance of Drugmart India.
Drugmart India Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.27% increase. The company also saw a substantial fall in profitability, with a 138.39% decrease in profit. The company's net worth dipped by a decrease of 3.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Drugmart India?
In 2020, Drugmart India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹5.68 M
Charges Breakdown by Lending Institutions
- Others : 0.57 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 29 Nov 2014 | Others | ₹5.68 M | Satisfied |
How Many Employees Work at Drugmart India?
Unlock and access historical data on people associated with Drugmart India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Drugmart India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Drugmart India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
